Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients. | Kidney Int Rep;7(11): 2537-2538, 2022 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients.

Aqeel, Faten; Geetha, Duvuru.

Aqeel F; Department of Internal Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Geetha D; Department of Internal Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Kidney Int Rep ; 7(11): 2537-2538, 2022 Nov.

Article in English | MEDLINE | ID: covidwho-2084425

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Kidney Int Rep Year: 2022 Document Type: Article Affiliation country: J.ekir.2022.08.019

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Kidney Int Rep Year: 2022 Document Type: Article Affiliation country: J.ekir.2022.08.019